It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining.

Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with NSW Health Pathology for one million SARS-CoV-2 Rhinoswabs as part of the department’s program to support testing capability.

The Rhinoswab technology aims to improve the sample collection process, and with extensive testing, was proven to be substantially more comfortable and easier to use than the standard nasal swab, while capturing a larger sample.

“The Rhinoswab can make a meaningful impact on the SARS-CoV-2 testing process and enable more people to be tested quickly and easily,” Rhinomed CEO Michael Johnson said.

“With approximately 2 billion SARS-CoV-2 tests having been carried out globally over the last 18 months, there is a major opportunity for Rhinoswab to radically improve the testing process, clinical outcomes and user experience.”

The next cab off the ranks was Respiri Limited (ASX:RSH) which rose a respectable 55% on nothing but a presentation detailing its commercialisation plans for its wheezo asthma management wheeze-detecting device and app.

Dimerix (ASX:DXB) was up 36% after securing $20 million in funding for pivotal Phase 3 trials for the company’s proprietary DMX-200 formula in the treatment of FSGS kidney disease.

And up 25% was Neuren Pharmaceuticals (ASX:NEU) after announcing  it has completed Phase 3 enrolment for the study of trofinetide in Rett syndrome (neuro-development disorder), with results on track to be published in Q4 of 2021.

Nova EYE Medical (ASX:EYE) was up 21% on no news, and Telix Pharmaceutical (ASX:TLX) jumped 15% on the news that London-based Great Ormond Street Hospital has received a UK research ethics approval to commence a Phase II academic study of Telix’s investigational product, TLX66 (90Y-DTPA-besilesomab) for use in children with high-risk leukemia.

 

Here’s a table showing how ASX-listed healthcare stocks have been performing.

Code Company Price %Yr %Wk MktCap
RNO Rhinomed Ltd 0.37 357 85 $ 92,640,333.18
RSH Respiri Limited 0.099 -32 52 $ 71,561,238.21
DXB Dimerix Ltd 0.305 -47 36 $ 66,329,764.50
NEU Neuren Pharmaceut. 2.3 80 25 $ 271,621,215.96
EYE Nova EYE Medical Ltd 0.44 47 21 $ 62,503,470.03
TLX Telix Pharmaceutical 6.12 352 15 $ 1,774,227,470.40
CBL Control Bionics 0.745 15 $ 35,426,326.85
PXS Pharmaxis Ltd 0.11 0 15 $ 54,350,899.68
CTE Cryosite Limited 0.455 168 14 $ 21,086,803.35
PTX Prescient Ltd 0.1975 213 13 $ 131,728,811.44
IBX Imagion Biosys Ltd 0.078 -8 11 $ 81,327,864.46
AMT Allegra Orthopaedics 0.25 0 11 $ 26,114,800.75
1AD Adalta Limited 0.09 -18 10 $ 21,085,443.71
SDI SDI Limited 0.97 45 9 $ 116,488,219.40
EXL Elixinol Wellness 0.125 -26 9 $ 39,382,894.25
ATX Amplia Therapeutics 0.2 33 8 $ 24,340,161.30
CPH Creso Pharma Ltd 0.135 200 8 $ 161,536,137.57
BD1 Bard1 Life Sciences 1.425 53 8 $ 128,768,483.73
MDR Medadvisor Limited 0.36 -25 7 $ 139,631,716.66
BNO Bionomics Limited 0.1925 135 7 $ 196,481,365.08
IMU Imugene Limited 0.2975 431 6 $ 1,591,994,197.80
CYP Cynata Therapeutics 0.51 -24 6 $ 71,638,297.00
CYC Cyclopharm Limited 1.68 14 6 $ 158,270,324.99
IPD Impedimed Limited 0.105 31 6 $ 156,885,907.40
MDC Medlab Clinical Ltd 0.18 24 6 $ 61,591,620.78
IHL Incannex Healthcare 0.28 383 6 $ 293,878,839.93
VLS Vita Life Sciences.. 1.13 60 6 $ 57,917,873.20
HCT Holista CollTech Ltd 0.064 -3 5 $ 17,346,992.48
GSS Genetic Signatures 1.32 -43 4 $ 192,924,782.10
MMJ MMJ Group Hlds Ltd 0.081 -16 4 $ 17,936,410.83
ACW Actinogen Medical 0.086 282 4 $ 144,468,593.59
NXS Next Science Limited 1.49 7 3 $ 296,960,863.50
EPN Epsilon Healthcare 0.155 -40 3 $ 29,869,577.10
OPT Opthea Limited 1.28 -46 3 $ 465,079,691.83
PAL Palla Pharma Ltd 0.36 -56 3 $ 59,907,870.31
PAB Patrys Limited 0.039 227 3 $ 70,964,279.30
TD1 Tali Digital Limited 0.046 64 2 $ 42,867,666.29
AGH Althea Group 0.29 -17 2 $ 73,464,591.20
OSX Osteopore Limited 0.38 -38 1 $ 31,215,120.00
CAJ Capitol Health 0.385 83 1 $ 400,958,029.68
BOT Botanix Pharma Ltd 0.079 52 1 $ 74,931,939.70
KZA Kazia Therapeutics 1.245 55 1 $ 163,039,217.07
AC8 Auscann Grp Hlgs Ltd 0.098 -35 1 $ 43,614,163.89
PBP Probiotec Limited 2.15 6 1 $ 167,911,688.84
LDX Lumos Diagnostics 1.26 1 $ 185,438,230.06
SOM SomnoMed Limited 2.35 82 0 $ 195,311,983.40
SCU Stemcell United Ltd 0.016 33 0 $ 16,693,130.53
RHT Resonance Health 0.135 -7 0 $ 62,215,017.44
ONT 1300 Smiles Limited 7.08 10 0 $ 167,642,958.72
NSB Neuroscientific 0.29 26 0 $ 42,324,134.69
MEB Medibio Limited 0.0075 -38 0 $ 12,565,430.49
M7T Mach7 Tech Limited 0.99 5 0 $ 241,227,670.32
LCT Living Cell Tech. 0.012 -14 0 $ 6,857,291.77
JHC Japara Healthcare Lt 1.38 191 0 $ 368,801,312.64
IVX Invion Ltd 0.013 30 0 $ 72,014,049.84
IMC Immuron Limited 0.16 -56 0 $ 36,359,455.36
IDT IDT Australia Ltd 0.38 124 0 $ 92,346,165.45
ICS ICSGlobal Limited 0.575313 16 0 $ 6,054,604.94
ICR Intelicare Holdings 0.14 -60 0 $ 6,573,088.34
GTG Genetic Technologies 0.007 -30 0 $ 73,808,721.14
BXN Bioxyne Ltd 0.03 150 0 $ 19,204,361.94
ALT Analytica Limited 0.002 0 0 $ 9,227,602.26
AHK Ark Mines Limited 0.034 0 0 $ 1,778,919.95
ADR Adherium Ltd 0.016 -36 0 $ 34,065,375.36
ACR Acrux Limited 0.13 -24 0 $ 36,829,701.22
1ST 1St Group Ltd 0.019 -44 0 $ 8,492,338.06
PSQ Pacific Smiles Grp 2.33 55 0 $ 382,996,651.20
ARX Aroa Biosurgery 1.08 -23 0 $ 372,147,210.31
MVF Monash IVF Group Ltd 0.93 66 -1 $ 364,308,575.40
BWX BWX Limited 5.02 25 -1 $ 729,145,275.84
PNV Polynovo Limited 2.19 -2 -1 $ 1,474,895,338.12
LBT LBT Innovations 0.099 -27 -1 $ 28,622,401.24
RGS Regeneus Ltd 0.083 -41 -1 $ 25,193,684.13
MVP Medical Developments 4.13 -35 -1 $ 301,449,562.56
ALC Alcidion Group Ltd 0.355 154 -1 $ 377,304,858.72
ILA Island Pharma 0.345 -1 $ 15,030,108.10
FFC Farmaforce Ltd 0.066 27 -1 $ 8,624,944.68
CHM Chimeric Therapeutic 0.32 -2 $ 64,954,993.95
MEM Memphasys Ltd 0.062 -60 -2 $ 47,167,980.56
NYR Nyrada Inc. 0.295 48 -2 $ 35,641,825.63
BIT Biotron Limited 0.057 -43 -2 $ 40,712,097.35
PCK Painchek Ltd 0.056 -49 -2 $ 60,847,459.15
UBI Universal Biosensors 0.78 179 -2 $ 136,812,457.32
PGC Paragon Care Limited 0.255 50 -2 $ 87,850,175.92
PAA Pharmaust Limited 0.092 -53 -2 $ 29,139,152.64
VHT Volpara Health Tech 1.085 -17 -2 $ 280,216,315.32
MXC Mgc Pharmaceuticals 0.04 60 -2 $ 95,724,793.01
LSH Lifespot Health Ltd 0.095 172 -3 $ 16,341,294.83
CAN Cann Group Ltd 0.305 -38 -3 $ 91,624,527.02
AHC Austco Healthcare 0.145 93 -3 $ 41,207,397.90
PAR Paradigm Bio. 1.835 -36 -3 $ 427,190,762.52
OSP Osprey Med Inc 0.0135 -63 -4 $ 33,355,143.61
CDY Cellmid Limited 0.051 -50 -4 $ 9,558,958.56
CDX Cardiex Limited 0.066 25 -4 $ 60,192,480.08
RCE Recce Pharmaceutical 0.87 -32 -4 $ 152,924,505.36
ZLD Zelira Therapeutics 0.041 -23 -5 $ 48,803,241.61
EZZ EZZ Life Science 0.405 -5 $ 4,860,000.00
NC6 Nanollose Limited 0.1 108 -5 $ 14,571,264.06
TRU Truscreen 0.058 -5 $ 23,223,440.19
CGS Cogstate Ltd 1.6 146 -5 $ 287,260,396.08
NOX Noxopharm Limited 0.55 69 -5 $ 167,172,468.52
ONE Oneview Healthcare 0.355 607 -5 $ 158,141,817.35
AT1 Atomo Diagnostics 0.2175 -42 -5 $ 89,911,874.14
OSL Oncosil Medical 0.05 -52 -6 $ 40,664,507.99
SUD Suda Pharmaceuticals 0.049 26 -6 $ 24,521,819.29
SHG Singular Health 0.245 -6 $ 16,820,305.32
BPH BPH Energy Ltd 0.065 225 -6 $ 43,219,760.29
ATH Alterity Therap Ltd 0.032 -45 -6 $ 77,019,986.50
ZNO Zoono Group Ltd 0.605 -74 -6 $ 100,718,751.27
PYC PYC Therapeutics 0.15 31 -6 $ 493,043,545.97
HXL Hexima 0.225 -26 -6 $ 27,083,792.03
OIL Optiscan Imaging 0.215 306 -7 $ 132,635,779.43
PIQ Proteomics Int Lab 1.055 61 -7 $ 112,623,786.25
RHY Rhythm Biosciences 0.905 725 -7 $ 185,054,917.07
OCC Orthocell Limited 0.505 44 -7 $ 100,102,834.65
CMP Compumedics Limited 0.44 -6 -7 $ 82,380,770.82
ADO Anteotech Ltd 0.185 243 -8 $ 364,514,142.46
VBS Vectus Biosystems 1.19 40 -8 $ 37,669,918.86
NTI Neurotech Intl 0.047 370 -8 $ 33,447,318.05
JTL Jayex Technology Ltd 0.023 -23 -8 $ 5,070,436.92
DVL Dorsavi Ltd 0.023 5 -8 $ 8,071,449.16
RAP Resapp Health Ltd 0.043 -70 -9 $ 37,804,671.39
OVN Oventus Medical Ltd 0.096 -64 -9 $ 23,930,926.97
IMM Immutep Ltd 0.465 158 -9 $ 404,188,330.48
APH AP Hemp Ltd 0.31 121 -9 $ 24,833,293.88
4DX 4Dmedical Limited 1.535 -8 -9 $ 315,523,202.13
DOC Doctor Care Anywhere 0.725 -9 $ 132,762,459.46
S66 Star Combo 0.32 -3 -10 $ 43,107,990.08
VTI Vision Tech, Inc 1 -38 -10 $ 24,344,565.00
BDX Bcaldiagnostics 0.16 -11 $ 21,044,249.92
AVE Avecho Biotech Ltd 0.016 100 -11 $ 27,541,747.89
RAC Race Oncology Ltd 2.93 233 -12 $ 440,422,571.15
GLH Global Health Ltd 0.45 67 -14 $ 26,869,669.38
ANP Antisense Therapeut. 0.17 113 -15 $ 94,788,596.60
MX1 Micro-X Limited 0.235 42 -18 $ 119,522,452.40

 

Flat this fortnight was Genetic Technologies (ASX:GTG) despite completing the acquisition of EasyDNA for US$4 million in cash and scrip on 13 August – which currently sells paternity, oncology and health & wellness genomics-based laboratory tests through agreements with 12 laboratories in North America, AsiaPac and Europe.

“The strong alignment of this brand and platform with GTG’s planned expansion into ‘health and wellness’ testing was critical to our decision to acquire the business of EasyDNA and will deliver solid revenue growth and expansion in the future,” GTG CEO Simon Morriss said.

And Aroa Biosurgery (ASX:ARX) joined the flat pack, even with the announcement that a new retrospective study of real-world data in the International Wound Journal showing significantly improved wound closure times for diabetic foot ulcers and much greater probability of wound closure in wounds treated with its Endoform Natural – compared to wounds treated with a traditional collagen dressing.

 

Who’s the biggest loser?

Micro-X Limited (ASX:MX1) was the biggest loser, down 18%, followed by Antisense Therapeutics (ASX:ANP) down 15% – both on no news.

Dropping 14% was Global Health (ASX:GLH) despite announcing a new non-executive, independent director in Karen Corry and a new chief financial officer in Ershad Ali.

Race Oncology (ASX:RAC) dropped 12% after announcing that the first patient was dosed in the Phase 1b/2 trial in relapsed/refractory acute myeloid leukaemia at the Chaim Sheba Medical Centre in Israel.

 
At Stockhead, we tell it like it is. While Dimerix and Respiri are Stockhead advertisers, they did not sponsor this article.